April 17, 2006
Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industries, today announced that Nader Naeymi-Rad, Senior Vice President and head of its Brand Management practice, will present a session at the 2nd Annual Forum on Early Stage Commercialization Strategies for the Bio/Pharmaceutical Industry hosted by the Center for Business Intelligence (
Mr. Naeymi-Rad’s session, titled “A Systematic Approach to New Product Planning,” will be presented on April 20 from to
In his role at Campbell Alliance, Mr. Naeymi-Rad, along with his Brand Management team, work closely with both large and emerging pharmaceutical and biotech companies to proactively manage their products’ lifecycles—from as early as phase 2 of clinical development through product launch—and to identify new indications for products to extend their brand life.
“Early decisions regarding the commercialization of a key compound can have far-reaching ramifications in terms of the company’s financial outlook, as well as on its ability to finance the development of other drugs in its pipeline. With the pharmaceutical and biotech industry’s focus on maintaining a robust pipeline of drugs in development, having an effective, process-driven approach to new product planning, and product lifecycle management overall, is more important than ever,” stated Naeymi-Rad.
For more information on
About the Brand Management Practice at
The Brand Management practice at Campbell Alliance can help enhance the commercial performance of products from initial launch through product maturity. The firm’s team members are experts at new product planning, commercial strategy development, brand planning, product launch, and myriad other aspects of maximizing the value of pharmaceutical assets. The team has also developed commercial strategies and programs in various geographic markets, including the